LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1159 | 5505 | 0.2106 | -0.1294 |
BT-20 | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 2475 | 5505 | 0.4495 | 0.2124 |
BT-20 | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 1657 | 6589 | 5505 | 1.1969 | 1.2817 |
BT-20 | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4827 | 5505 | 0.8768 | 0.8237 |
BT-20 | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1624 | 5505 | 0.2950 | -0.0087 |
BT-20 | R406 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4966 | 5505 | 0.9020 | 0.8598 |
BT-20 | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1746 | 5505 | 0.3173 | 0.0231 |
BT-20 | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4857 | 5505 | 0.8822 | 0.8315 |
BT-20 | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1735 | 5505 | 0.3153 | 0.0203 |
BT-20 | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1656 | 5505 | 0.3008 | -0.0005 |
BT-20 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 968 | 5505 | 0.1758 | -0.1793 |
BT-20 | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1111 | 5505 | 0.2019 | -0.1419 |
BT-20 | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 1657 | 5204 | 5505 | 0.9453 | 0.9217 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1218 | 5505 | 0.2212 | -0.1143 |
BT-20 | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 3450 | 5505 | 0.6266 | 0.4658 |
BT-20 | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1241 | 5505 | 0.2255 | -0.1082 |
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 2727 | 5505 | 0.4954 | 0.2781 |
BT-20 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4472 | 5505 | 0.8123 | 0.7315 |
BT-20 | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 5506 | 5505 | 1.0001 | 1.0002 |
BT-20 | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1519 | 5505 | 0.2760 | -0.0360 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4050 | 5505 | 0.7356 | 0.6217 |
BT-20 | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4868 | 5505 | 0.8842 | 0.8344 |
BT-20 | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 2144 | 5505 | 0.3895 | 0.1265 |
BT-20 | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 5543 | 5505 | 1.0068 | 1.0097 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4834 | 5505 | 0.8781 | 0.8255 |